1-3 of 3
Yoram Reiter
Close
Sort by
Journal Articles

Targeting Leukemia Initiating Cells by MUC1-C Subunit Inhibition

Dina Stroopinsky, PhD, Jacalyn Rosenblatt, MD, Heidi Mills, Caterina Nardella, Keisuke Ito, MD, PhD, Li Yin, Hasan Rajabi, PhD, Baldev Vasir, PhD, Turner Kufe, Katarina Luptakova, MD, Jon E. Arnason, MD, James D. Levine, MD, Robin Joyce, MD, Dimitrios Tzachanis, MD, PhD, Vassiliki A. Boussiotis, MD, PhD, Ilene Galinsky, ANP, Richard M. Stone, MD, Yoram Reiter, PhD, Pier Paolo Pandolfi, MD, PhD, Donald Kufe, MD, David Avigan, MD
Journal: Blood
Blood (2012) 120 (21): 3583.
https://doi.org/10.1182/blood.V120.21.3583.3583
Published: 2012
Journal Articles

MUC1 Inhibition Reverses the Poor Immunogenicity of Leukemia Stem Cells Rendering Them Susceptible to Immunotherapy

Dina Stroopinsky, PhD, Jacalyn Rosenblatt, MD, Heidi Mills, BA, Katarina Luptakova, MD, Brett Glotzbecker, MD, Baldev Vasir, PhD, Robin Joyce, MD, James Levine, MD, Dimitrios Tzachanis, MD, PhD, Jon E. Arnason, MD, Ilene Galinsky, ANP, Richard M. Stone, MD, Donald Kufe, MD, Yoram Reiter, PhD, David Avigan, MD
Journal: Blood
Blood (2011) 118 (21): 1883.
https://doi.org/10.1182/blood.V118.21.1883.1883
Published: 2011
Journal Articles

Cross-priming CD8 + T cells by targeting antigens to human dendritic cells through DCIR

Eynav Klechevsky, Anne-Laure Flamar, Yanying Cao, Jean-Philippe Blanck, Maochang Liu, Amy O'Bar, Olivier Agouna-Deciat, Peter Klucar, LuAnn Thompson-Snipes, Sandra Zurawski, Yoram Reiter, A. Karolina Palucka, Gerard Zurawski, Jacques Banchereau
Journal: Blood
Blood (2010) 116 (10): 1685–1697.
https://doi.org/10.1182/blood-2010-01-264960
Published: 2010
Includes: Supplemental data